Evidence Checklist: Bronchiectasis

High-resolution CT scan confirming bronchiectasisCritical

HRCT is the definitive imaging modality for bronchiectasis, showing bronchial dilation (airway diameter exceeding its adjacent pulmonary artery), bronchial wall thickening, and distribution of affected airways.

Pulmonary function tests (PFTs) with pre/post bronchodilatorCritical

Spirometry documenting the degree of airflow obstruction or restriction. FEV-1 percent predicted drives the VA rating for bronchiectasis.

Nexus opinion linking bronchiectasis to service ("at least as likely as not")Critical

A medical opinion connecting your bronchiectasis to in-service events such as severe or recurrent pneumonia, inhalational chemical exposure, burn pit exposure, or a service-connected lung condition.

Sputum culture results (bacterial, fungal, or mycobacterial)

Microbiological results documenting chronic airway infection — Pseudomonas aeruginosa, Haemophilus influenzae, or non-tuberculous mycobacteria (NTM) colonization is common and reflects disease severity.

Treatment records (airway clearance, antibiotics, inhalers)

Records documenting daily airway clearance techniques (chest physiotherapy, oscillatory PEP devices), inhaled bronchodilators, mucus-thinning agents, and antibiotic courses for exacerbations.

Documentation of exacerbation frequency and hospitalizations

Medical records showing the number and severity of acute exacerbations per year, emergency department visits, and hospitalizations, which reflect overall disease burden.

Buddy statement from spouse, family, or fellow service member

A written statement from someone who can describe observable symptoms and how your condition affects daily life.

Completed DBQ Respiratory ConditionsCritical

Standardized form capturing PFT results, imaging findings, exacerbation frequency, and functional impact of bronchiectasis.

Service treatment records (STRs)Critical

Military medical records showing in-service treatment, complaints, or injuries related to this condition.